(Reuters) — Patients with Type II diabetes who are overweight but not obese outlive diabetics of normal weight, scientists reported yesterday, in another example of the "obesity paradox."
The survival rate for high-risk patients with transcatheter aortic valve implants surpassed 61% at 3 years and drops to 45.5% at 5 years, according to a new analysis of data from the U.K. Transcatheter Aortic Valve Implantation Registry.
Medtronic (NYSE:MDT) today said it’s launching a study of a new, combination treatment for atrial fibrillation using renal denervation and cardiac ablation.